Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DoRa: Antithrombotic Effects of Doxazosin and Ramipril
NCT02901977Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Mar 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of doxazosin in hypertension (HTN) (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Thrombin-antithrombin complex generation at 12 weeks and Flow mediated vasodilatation at 12 weeks. Started Mar 2011; status: completed.
02
Drugs
doxazosin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02901977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901977.